Richard G. Vincent

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard G. Vincent

Form 4 holding Chief Financial Officer

Oncternal Therapeutics, Inc.

Security class
Common Stock
Shares / value
140,922
Estimated value
$69,911
Report date
03 Jan 2024
Price
$0.4961
Ownership
Direct
Form 4 holding Chief Financial Officer

Oncternal Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,526
Estimated value
$2,245
Report date
03 Jan 2024
Price
$0.4961
Ownership
By Family Trust
Form 4 holding Chief Financial Officer

Oncternal Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,834
Estimated value
$910
Report date
03 Jan 2024
Price
$0.4961
Ownership
By Child
Form 4 holding Director

Forte Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
31,000
Estimated value
Report date
20 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Oncternal Therapeutics, Inc.

Security class
Stock Option
Shares / value
14,200
Estimated value
Report date
14 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard G. Vincent

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .